Original Articles: Asthma, Lower Airway Diseases
Multicenter study of cigarette smoking among patients presenting to the emergency department with acute asthma

https://doi.org/10.1016/S1081-1206(10)60164-0Get rights and content

Background

Many studies have focused on smoking and chronic asthma severity. However, research on the relationship between smoking and acute asthma severity in an acute care setting is sparse.

Objectives

To determine the smoking prevalence among emergency department (ED) patients with acute asthma and to investigate the relationships between smoking and acute asthma severity.

Methods

A 63-site medical record review study of ED patients, ages 14 to 54 years, with a principal diagnosis of acute asthma was performed. Patients with chronic obstructive pulmonary disease were excluded. Measurements for acute asthma severity included sociodemographic factors, asthma medical history, ED presentation, clinical course, medications administered, and return visit within 48 hours.

Results

A total of 4,052 patient medical records were reviewed. A total of 1,332 patients (33%; 95% confidence interval, 31%–34%) were documented as smokers. No statistically significant differences were found between smokers and nonsmokers in vital signs, oxygen saturation, peak expiratory flow, and administration of asthma medications. By contrast, smokers were more likely than nonsmokers to receive antibiotics in the ED (12% vs 9%, P < .001) or at discharge (23% vs 14%, P < .001). A multivariate analysis confirmed that smoking status was independently associated with antibiotic administration (odds ratio, 1.6; 95% confidence interval, 1.3–1.8).

Conclusions

One-third of ED patients with acute asthma smoked cigarettes. Smokers and nonsmokers did not differ in their acute asthma severity. Asthmatic smokers, however, were more likely to receive antibiotics, even when adjusting for other possible confounders.

Section snippets

INTRODUCTION

Cigarette smoking has profound deleterious effects on the respiratory system. It initiates microscopic changes at a cellular level with the apoptosis of alveolar cells and endothelial cell malfunction,1, 2 creating an environment that leads to macroscopic structural and functional destruction. Over time, these cumulative insults cause a progressive deterioration in pulmonary function.3, 4, 5, 6

The deterioration of pulmonary function is worse in patients with asthma who smoke. Longitudinal

METHODS

The National Emergency Department Safety Study was a patient safety study based in US EDs. Details of the study’s methods have been published previously.13 Our analysis used data from the study’s asthma medical record review component.

A total of 63 EDs participated, with most sites (n = 48) being academic EDs (ie, affiliated with an emergency medicine residency program). Patients were included in this study if they were between the ages of 14 and 54 years and had a principal ED or hospital

RESULTS

A total of 4,052 medical records of patients with acute asthma were reviewed, and 33% (95% CI, 31%–34%) were found to smoke cigarettes. The median age of the smokers was 34 years (IQR, 24–43 years); 64% were women, and 47% were black. Compared with nonsmokers, smokers were more likely to be older and male (Table 1). No statistically significant differences were found in race/ethnicity and medical history pertaining to asthma between both groups.

Nonsmokers were more likely to be prescribed

DISCUSSION

The prevalence of smoking among asthmatic patients who present to EDs in our sample was 33% (95% CI, 31%–34%), which is similar to the prevalence of 35% found by Silverman et al11 in 1996 to 1998. Although there has been a steady decrease in the rate of smoking in the US adult population during the past 10 years to 21%,19 there seems to be no change in prevalence of smoking among individuals with asthma who present to EDs. This persistently high prevalence of smoking among patients with asthma

REFERENCES (44)

  • OngS et al.

    Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction

    Ann Emerg Med

    (2007)
  • BramanSS

    Chronic cough due to acute bronchits: ACCP evidence-based clinical practice guidelines

    Chest

    (2006)
  • HoshinoY et al.

    Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line

    Am J Physiol Lung Cell Mol Physiol

    (2001)
  • LangeP et al.

    A 15-year follow-up study of ventilatory function in adults with asthma

    N Engl J Med

    (1998)
  • JamesAL et al.

    Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking

    Am J Respir Crit Care Med

    (2005)
  • BurchfielCM et al.

    Effects of smoking and smoking cessation on longitudinal decline in pulmonary function

    Am J Respir Crit Care Med

    (1995)
  • ApostolGG et al.

    Early life factors contribute to the decrease in lung function between ages 18 and 40: the coronary artery risk development in young adults study

    Am J Respir Crit Care Med

    (2002)
  • AlthuisMD et al.

    Cigarette smoking and asthma symptom severity among adult asthmatics

    J Asthma

    (1999)
  • SirouxV et al.

    Relationships of active smoking to asthma and asthma severity in the EGEA study

    Eur Respir J

    (2000)
  • SuzukiK et al.

    Respiratory symptoms and cigarette smoking in 3,197 pulmonologist-based asthmatic patients with a highly prevalent use of inhaled corticosteroid

    J Asthma

    (2003)
  • ShavitO et al.

    Impact of smoking on asthma symptoms, healthcare resource use, and quality of life outcomes in adults with persistent asthma

    Qual Life Res

    (2007)
  • NawarEW et al.

    National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary

    Adv Data

    (2007)
  • Cited by (21)

    • Multicenter study of cigarette smoking among adults with asthma exacerbations in the emergency department, 2011–2012

      2017, Respiratory Medicine
      Citation Excerpt :

      Additionally, current and former smokers are more likely to need emergency care, with approximately 10% of emergency department (ED) visits for asthma exacerbations attributed to smoking [4]. Our previous studies through the late 1990s to early 2000s documented smoking rates between 33% and 35% in ED patients with asthma exacerbations [5,6]. Despite the clinical and public health importance of this topic, no recent multicenter efforts characterize this patient population.

    • Emergency Treatment and Approach to the Patient with Acute Asthma

      2014, Middleton's Allergy: Principles and Practice: Eighth Edition
    • Quality of Care for Acute Asthma in Emergency Departments in Japan: A Multicenter Observational Study

      2013, Journal of Allergy and Clinical Immunology: In Practice
      Citation Excerpt :

      Data abstraction was done with a standardized form and included patients' demographics, past asthma history, current asthma medications, patient presentation, PEF, treatment (in the ED or at discharge), and disposition. This standardized form was used in multiple US-based studies conducted by the Emergency Medicine Network.15-22 On the basis of common recommendations contained in the 2007 NIH asthma guidelines6 and using methods similar to those in the National Emergency Department Safety study with acute asthma,9 we derived a priori 8 explicit process measures, which included 5 level A and 3 level B evidence-based treatments (see Table E2 in this article's Online Repository at www.jaci-inpractice.org).

    • Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008

      2012, Journal of Allergy and Clinical Immunology
      Citation Excerpt :

      However, we have conducted sensitivity analyses to address this issue, and the results did not materially change. In addition, the smoking rates in the NEDS asthma population were comparable with those from our previous multicenter study of adults with acute asthma.53 Second, the NEDS contains visit-level records and not patient-level records.

    View all citing articles on Scopus

    Disclosures: Dr Camargo has received financial support from a variety of groups for participation in conferences, consulting, and medical research. Recent industry sponsors with an interest in asthma were AstraZeneca, Critical Therapeutics, Dey, GSK, Merck, Novartis, Respironics, and Schering-Plough. The other authors have no declared conflicts of interest.

    Funding Sources: The National Emergency Department Safety Study was supported by grant R01 HS-13099 from the Agency for Healthcare Research and Quality (Rockville, Maryland).

    View full text